v3.26.1
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

17. SHARE-BASED COMPENSATION

 

(a) Share options

 

In 2018, the Company adopted 2018 Second Amended and Restated Incentive Plan (“2018 Second Plan”).

 

The Company accounts for share-based compensation costs using a graded-vesting method over the requisite service period for the award based on the fair value on their respectively grant date.

 

The following table sets forth the share option activities for the fiscal year ended March 31, 2024, the nine months ended December 31, 2024 and the year ended December 31, 2025:

 

SCHEDULE OF SHARE OPTION ACTIVITY

   Number of shares   Weighted-average exercise price   Weighted average remaining contractual term   Aggregate
intrinsic
value
   Weighted average fair value of options 
       US$   YEARS   US$’000   US$ 
                     
Outstanding as of March 31, 2023   26,656,618    0.48    6.83    9,585.96    0.88 
                          
Granted   22,064,611    -*    -    -    0.04 
Forfeited   (4,522,500)   0.86    -    -    1.81 
Exercised   (6,880,590)   -*    -    -    0.11 
                          
Outstanding as of March 31, 2024   37,318,139    0.24    7.67    8,898.37    0.44 
                          
Granted   10,544,400    -*    -    -    0.01 
Forfeited   (2,078,339)   0.90    -    -    1.68 
Exercised   (14,181,600)   -*    -    -    0.04 
                          
Outstanding as of December 31, 2024   31,602,600    0.21    3.60    14,336.67    0.38 
                          
Granted   215,822,400    -*    -    -    0.01 
Forfeited   (6,758,400)   0.07    -    -    0.15 
Exercised   (170,400)   -*    -    -    0.14 
                          
Outstanding as of December 31, 2025   240,496,200    0.02    2.61    2,604.33    0.05 
Vested and expected to vest as of December 31, 2025   240,496,200    0.02    2.61    2,604.33    0.05 
Exercisable as of December 31, 2025   31,853,700    0.12    2.43    262.67    0.36 

 

*Less than 0.01.

 

As the granted option exercise prices were equal or close to nominal prices during the fiscal year ended March 31, 2024, the nine months ended December 31, 2024 and the year ended December 31, 2025, their fair values approximated the fair values of the Class A ordinary share on the grant day.

 

 

UXIN LIMITED

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except for share and per share data, unless otherwise noted)

 

17. SHARE-BASED COMPENSATION (CONTINUED)

 

(b) Restricted shares

 

The following table sets forth the restricted share activity for the fiscal year ended March 31, 2024, the nine months ended December 31, 2024 and the year ended December 31, 2025:

 

  

Number of

shares

  

Weighted average

grant date

fair value

 
       US$ 
         
Unvested as of March 31, 2023  -   - 
         
Granted   2,871,270    0.05 
Vested   (2,871,270)   0.05 
           
Unvested as of March 31, 2024   -    - 
           
Granted   -    - 
Vested   -    - 
           
Unvested as of December 31, 2024   -    - 
           
Granted   55,200,600    0.01 
Vested   (55,200,600)   0.01 
           
Unvested as of December 31, 2025   -    - 

 

 

UXIN LIMITED

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except for share and per share data, unless otherwise noted)

 

17. SHARE-BASED COMPENSATION (CONTINUED)

 

(c) Performance Awards

 

In December 2021, the Company issued certain restricted share units with market conditions to certain management (“Performance Awards”). The market conditions are satisfied upon the Company’s achievement of a certain specified market capitalization subject to continuous employment of each recipient. Total numbers of shares to be granted would be a certain percentage of issued and outstanding shares on a fully diluted basis as of the date when the market conditions are fulfilled. The amount of share-based compensation recorded will vary depending on the Company’s attainment of performance-targets and amortized during the requisite service period.

 

In October 2023 and August 2024, the Company modified the market conditions under the Performance Awards, resulting into an incremental fair value of RMB60.4 million and RMB73.7 million, respectively. The Company will recognize compensation cost equal to the unrecognized grant-date fair value of the original award plus the incremental fair value arising from the modification over the remaining requisite service period unless the respective market condition was actually met.

 

In October 2024, the market condition of the first tranche was satisfied, which is earlier than the initial estimation, and all remaining unrecognized fair value of the award relating to the first tranche was recognized immediately when the respective market condition was actually met. As of December 31, 2025, the shares relating to the first tranche of the Performance Awards had not yet been issued (“Unissued shares relating to the Performance Awards”).

 

For the fiscal year ended March 31, 2024, the nine months ended December 31, 2024 and the year ended December 31, 2025, RMB39.2 million, RMB84.3 million and RMB28.3 million related to Performance Awards was recorded in general and administrative expenses. As of December 31, 2025, total amount of unrecognized expense related to the Performance Awards was RMB45.5 million.

 

(d) Share-based compensation to Mr. Kun Dai

 

Please refer to Note 14 for the details of share-based compensation to Mr. Kun Dai.

 

(e) Share-based compensation expenses by function

 

The following table sets forth the amounts of share-based compensation expense included in each of the relevant financial statement line items:

 

  

For the fiscal

year ended

March 31,

  

For the nine

months ended

December 31,

  

For the year

ended

December 31,

 
   2024   2024   2025 
   RMB   RMB   RMB 
                
General and administrative expenses   72,942    84,663    36,780 
Research and development expenses   1,420    128    2,491 
Sales and marketing expenses   1,444    136    5,312 
Total   75,806    84,927    44,583 

 

 

UXIN LIMITED

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(All amounts in thousands, except for share and per share data, unless otherwise noted)